According to a recent statement from Eli Lilly's CEO, the company is significantly scaling back its German investment plan, which was initially set at €2.3 billion.
According to Eli Lilly's CEO, Dave Ricks, the company will significantly scale back its German investment from an initial €2.3 billion ($2.67 billion) to half that amount.
Related ↗A powerful earthquake measuring 7.8 magnitude hits the south of Philippines.A massive €1 billion investment has gone into the Alzey facility for producing weight-loss injections, as per a recent report from the German business daily, published yesterday on Wednesday.
Operations at the high-tech facility are now expected to commence in 2027, but on a significantly scaled-back scale, impacting approximately 500 positions initially.
Read next ↗New Obesity Treatment from Boehringer-Zealand Reduces Visceral Liver Fat Effectively.According to Ricks' statement, the abandoned investment amount for Germany will be redirected either to a facility in Pennsylvania or a brand-new location.
The US offers more favorable conditions than Europe for our investments, as stated by the CEO.
A significant move by Eli Lilly comes on the heels of proposed legislation in Germany to control escalating healthcare expenses.
Eli Lilly(LLY.N)Eli Lilly's CEO,Dave Ricks, the company will significantly scale back its German investment from an initial €2.3 billion ($2.67 billion) to half that amount.



